217 related articles for article (PubMed ID: 31149050)
21. Epidermal growth factor receptor mediated proliferation depends on increased lipid droplet density regulated via a negative regulatory loop with FOXO3/Sirtuin6.
Penrose H; Heller S; Cable C; Makboul R; Chadalawada G; Chen Y; Crawford SE; Savkovic SD
Biochem Biophys Res Commun; 2016 Jan; 469(3):370-6. PubMed ID: 26657850
[TBL] [Abstract][Full Text] [Related]
22. SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms.
Wang XX; Wang XL; Tong MM; Gan L; Chen H; Wu SS; Chen JX; Li RL; Wu Y; Zhang HY; Zhu Y; Li YX; He JH; Wang M; Jiang W
Basic Res Cardiol; 2016 Mar; 111(2):13. PubMed ID: 26786260
[TBL] [Abstract][Full Text] [Related]
23. SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.
Khongkow M; Olmos Y; Gong C; Gomes AR; Monteiro LJ; Yagüe E; Cavaco TB; Khongkow P; Man EP; Laohasinnarong S; Koo CY; Harada-Shoji N; Tsang JW; Coombes RC; Schwer B; Khoo US; Lam EW
Carcinogenesis; 2013 Jul; 34(7):1476-86. PubMed ID: 23514751
[TBL] [Abstract][Full Text] [Related]
24. SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
Yu Y; Peng K; Li H; Zhuang R; Wang Y; Li W; Yu S; Liang L; Xu X; Liu T
Oncol Rep; 2018 May; 39(5):2235-2242. PubMed ID: 29565456
[TBL] [Abstract][Full Text] [Related]
25. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
26. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
[TBL] [Abstract][Full Text] [Related]
27. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
Dey P; Ström A; Gustafsson JÅ
Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
[TBL] [Abstract][Full Text] [Related]
29. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract][Full Text] [Related]
30. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
31. OSI-027 inhibits the tumorigenesis of colon cancer through mediation of c-Myc/FOXO3a/PUMA axis.
Lou J; Lv JX; Zhang YP; Liu ZJ
Cell Biol Int; 2022 Aug; 46(8):1204-1214. PubMed ID: 35293663
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the FoxO3a transcription factor is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated senescence in human colon cancer and breast cancer cells.
Park SY; Bae YS
Biochem Biophys Res Commun; 2016 Sep; 478(1):18-24. PubMed ID: 27470586
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma.
Geng CH; Zhang CL; Zhang JY; Gao P; He M; Li YL
J Cell Biochem; 2018 May; 119(5):3957-3967. PubMed ID: 29227545
[TBL] [Abstract][Full Text] [Related]
34. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
35. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
[TBL] [Abstract][Full Text] [Related]
36. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
Li C; Xiao XQ; Qian YH; Zhou ZY
J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.
Germani A; Matrone A; Grossi V; Peserico A; Sanese P; Liuzzi M; Palermo R; Murzilli S; Campese AF; Ingravallo G; Canettieri G; Tezil T; Simone C
Cancer Lett; 2014 Mar; 344(1):110-118. PubMed ID: 24215867
[TBL] [Abstract][Full Text] [Related]
38. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
Zhou J; Wu A; Yu X; Zhu J; Dai H
Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
[TBL] [Abstract][Full Text] [Related]
39. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
40. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
